Axicabtagene Ciloleucel for Consolidation After First-line Treatment of High-risk Large B-cell Lymphoma

NCT06609304 · clinicaltrials.gov ↗

PHASE4

Phase

RECRUITING

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Lymphoma, B-Cell

Interventions

BIOLOGICAL: Axicabtagene Ciloleucel

Sponsor

Zhengzhou University